Single-Arm Open-Label Multicenter Study of VB-111 in Patients With Recurrent Glioblastoma Multiforme
Clinical trial NCT01260506 · COMPLETED
Trial details
- NCT number
- NCT01260506
- Sponsor
- Vascular Biogenics Ltd. operating as VBL Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-12-01
- Primary completion
- 2015-07-23
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.